{"id":"https://openalex.org/W7224552199","doi":"https://doi.org/10.1080/00397911.2026.2744249","title":"Recent advances in synthesis and anticancer evaluation of oxadiazole scaffold","display_name":"Recent advances in synthesis and anticancer evaluation of oxadiazole scaffold","publication_year":2026,"publication_date":"2026-10-29","ids":{"openalex":"https://openalex.org/W7224552199","doi":"https://doi.org/10.1080/00397911.2026.2744249"},"language":"en","primary_location":{"id":"doi:10.1080/00397911.2026.2744249","doi":"https://doi.org/10.1080/00397911.2026.2744249","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00397911.2026.2744249","pdf_url":null,"source":{"id":"https://openalex.org/S114976158","display_name":"Synthetic Communications","issn_l":"0039-7911","issn":["0039-7911","1532-2432"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synthetic Communications","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160094467","display_name":"Ashvini A. Jadhav","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165259314","display_name":"Dr. Babasaheb Ambedkar Marathwada University","ror":"https://ror.org/033pfj584","country_code":"IN","type":"education","lineage":["https://openalex.org/I165259314"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ashvini A. Jadhav","raw_affiliation_strings":["Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University","institution_ids":["https://openalex.org/I165259314"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084716706","display_name":"Anusaya S. Chavan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165259314","display_name":"Dr. Babasaheb Ambedkar Marathwada University","ror":"https://ror.org/033pfj584","country_code":"IN","type":"education","lineage":["https://openalex.org/I165259314"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Anusaya S. Chavan","raw_affiliation_strings":["Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University","institution_ids":["https://openalex.org/I165259314"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5084716706"],"corresponding_institution_ids":["https://openalex.org/I165259314"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.71970243,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1","last_page":"31"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.6304000020027161,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.6304000020027161,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12410","display_name":"Structural and Chemical Analysis of Organic and Inorganic Compounds","score":0.36329999566078186,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oxadiazole-derivatives","display_name":"oxadiazole derivatives","score":0.9829999804496765},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.824999988079071},{"id":"https://openalex.org/keywords/heterocyclic-scaffolds","display_name":"heterocyclic scaffolds","score":0.9509999752044678},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7910000085830688},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.906000018119812},{"id":"https://openalex.org/keywords/microtubule-polymerization","display_name":"microtubule assembly","score":0.7730000019073486},{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.9399999976158142},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor-receptor-2","display_name":"vascular endothelial growth factor receptor 2","score":0.972000002861023},{"id":"https://openalex.org/keywords/topoisomerases","display_name":"topoisomerases","score":0.9850000143051147},{"id":"https://openalex.org/keywords/histone-deacetylase","display_name":"histone deacetylase","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hybrid-molecules","display_name":"hybrid molecules","score":0.925000011920929},{"id":"https://openalex.org/keywords/tumor-selectivity","display_name":"tumor selectivity","score":0.7799999713897705},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.42800000309944153}],"concepts":[{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.847599983215332},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7939000129699707},{"id":"https://openalex.org/C2779448499","wikidata":"https://www.wikidata.org/wiki/Q1227206","display_name":"Oxadiazole","level":2,"score":0.6111000180244446},{"id":"https://openalex.org/C89429830","wikidata":"https://www.wikidata.org/wiki/Q735710","display_name":"Scaffold","level":2,"score":0.48730000853538513},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.4049000144004822},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3887999951839447},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3797999918460846},{"id":"https://openalex.org/C53105671","wikidata":"https://www.wikidata.org/wiki/Q14777816","display_name":"Rational design","level":2,"score":0.36419999599456787},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.34549999237060547},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3431999981403351},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.32910001277923584},{"id":"https://openalex.org/C2994372470","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell lines","level":4,"score":0.3249000012874603},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.31940001249313354},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.3100000023841858},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.30889999866485596},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.30390000343322754},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.29899999499320984},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.28870001435279846},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.28279998898506165},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2766000032424927},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.27219998836517334},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2718000113964081},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.266400009393692},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.2621999979019165},{"id":"https://openalex.org/C84425145","wikidata":"https://www.wikidata.org/wiki/Q422492","display_name":"Tubulin","level":3,"score":0.2563999891281128}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1080/00397911.2026.2744249","doi":"https://doi.org/10.1080/00397911.2026.2744249","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00397911.2026.2744249","pdf_url":null,"source":{"id":"https://openalex.org/S114976158","display_name":"Synthetic Communications","issn_l":"0039-7911","issn":["0039-7911","1532-2432"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synthetic Communications","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8999999761581421}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W2057966202","https://openalex.org/W2412284632","https://openalex.org/W2901153695","https://openalex.org/W2988992984","https://openalex.org/W3005700983","https://openalex.org/W3020893404","https://openalex.org/W3044388665","https://openalex.org/W3128646645","https://openalex.org/W4294238407","https://openalex.org/W4320032522","https://openalex.org/W4379145218","https://openalex.org/W4385295626","https://openalex.org/W4394818301","https://openalex.org/W4402140383","https://openalex.org/W4403005356","https://openalex.org/W4403129268","https://openalex.org/W4406404978","https://openalex.org/W4406741768","https://openalex.org/W4407341547","https://openalex.org/W4407418480","https://openalex.org/W4407583846","https://openalex.org/W4407843095","https://openalex.org/W4409002176","https://openalex.org/W4409716943","https://openalex.org/W4409787301","https://openalex.org/W4409838928","https://openalex.org/W4409951997","https://openalex.org/W4411433129","https://openalex.org/W4411522685","https://openalex.org/W4411612301","https://openalex.org/W4412628307","https://openalex.org/W4413177571","https://openalex.org/W4413920718","https://openalex.org/W4414091579","https://openalex.org/W4414264551","https://openalex.org/W4414481146","https://openalex.org/W4414816587","https://openalex.org/W4415130889","https://openalex.org/W4416660027","https://openalex.org/W4416757889","https://openalex.org/W4417498555","https://openalex.org/W7119501486"],"related_works":["https://openalex.org/W7142136319","https://openalex.org/W3095200711","https://openalex.org/W3133318572","https://openalex.org/W1930045581","https://openalex.org/W3087651260","https://openalex.org/W7220082323","https://openalex.org/W2788696203","https://openalex.org/W6911698875","https://openalex.org/W3015735246","https://openalex.org/W3180057491"],"abstract_inverted_index":{"Cancer":[0],"is":[1],"one":[2],"of":[3,7,28,66,119,129,144],"the":[4,11,26,97,112,116,133],"major":[5],"causes":[6],"death":[8],"worldwide,":[9],"emphasizing":[10,111],"critical":[12],"need":[13],"for":[14],"safer":[15],"and":[16,36,53,90,108,140],"more":[17],"effective":[18],"anticancer":[19,29,61,121,148],"drugs.":[20],"Heterocyclic":[21],"scaffolds":[22],"are":[23],"important":[24],"in":[25,115,132],"development":[27],"drugs":[30],"due":[31],"to":[32],"their":[33],"structural":[34],"variety":[35,65],"extensive":[37],"biological":[38,136],"activity;":[39],"among":[40],"these,":[41],"oxadiazole":[42,98,145],"has":[43],"emerged":[44],"as":[45,77,147],"a":[46,64,126],"notable":[47],"pharmacophore":[48],"with":[49],"excellent":[50],"physicochemical":[51],"features":[52],"exceptional":[54],"therapeutic":[55],"potential.":[56],"Oxadiazole-based":[57],"derivatives":[58,146],"have":[59,100],"strong":[60],"activity":[62],"against":[63],"human":[67],"cancer":[68,105],"cell":[69,106],"lines":[70],"by":[71],"targeting":[72],"key":[73],"molecular":[74,141],"pathways":[75],"such":[76],"tubulin":[78],"polymerization,":[79],"epidermal":[80],"growth":[81,86],"factor":[82,87],"receptor,":[83],"vascular":[84],"endothelial":[85],"receptor-2,":[88],"topoisomerases,":[89],"histone":[91],"deacetylases.":[92],"Furthermore,":[93],"hybrid":[94],"compounds":[95],"incorporating":[96],"scaffold":[99],"shown":[101],"improved":[102],"efficacy,":[103],"enhanced":[104],"selectivity,":[107],"lower":[109],"toxicity,":[110],"scaffold\u2019s":[113],"usefulness":[114],"rational":[117],"design":[118],"innovative":[120],"medicines.":[122,149],"This":[123],"study":[124],"provides":[125],"comprehensive":[127],"summary":[128],"recent":[130],"advances":[131],"design,":[134],"synthesis,":[135],"evaluation,":[137],"structure-activity":[138],"relationships,":[139],"docking":[142],"studies":[143]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-30T00:00:00"}